Drug development trends: insight from Thermo Fisher’s Anil Kane
European Pharmaceutical Review
DECEMBER 1, 2023
They could be for the oncology space, including different types of cancers, central nervous system indications such as Alzheimer’s, Parkinson’s and epilepsies, and also the most common indications for diabetes and other metabolic disorders. Also, we can expect to see the utilisation of digital technologies for predictive modelling.
Let's personalize your content